Cargando…
P1122: EFFICACY OF ALPELISIB IN PI3K-DRIVEN LANGERHANS CELL HISTIOCYTOSIS
Autores principales: | Mazor, R., Durham, B., Abdel-Wahab, O., Diamond, E., Itchaki, G., Ben-Sasson, M., Hershkovitz-Rokah, O., Shpilberg, O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429436/ http://dx.doi.org/10.1097/01.HS9.0000847356.18523.53 |
Ejemplares similares
-
MicroRNA-15a-5p acts as a tumor suppressor in histiocytosis by mediating CXCL10-ERK-LIN28a-let-7 axis
por: Weissman, Ran, et al.
Publicado: (2021) -
Dual BRAF/MEK blockade restores CNS responses in BRAF-mutant Erdheim–Chester disease patients following BRAF inhibitor monotherapy
por: Mazor, Roei D, et al.
Publicado: (2020) -
NAD(P)H Quinone Oxidoreductase Protects TAp63γ from Proteasomal Degradation and Regulates TAp63γ-Dependent Growth Arrest
por: Hershkovitz Rokah, Oshrat, et al.
Publicado: (2010) -
Langerhans cell histiocytosis
por: Aruna, D. R., et al.
Publicado: (2011) -
Langerhans cell histiocytosis
por: Kumar, Manish, et al.
Publicado: (2018)